Ziconotide Combination Intrathecal Therapy for Noncancer Pain Is Limited Secondary to Delayed Adverse Effects: A Case Series With a 24‐Month Follow‐Up
Publisher: John Wiley & Sons Inc
E-ISSN: 1525-1403|18|5|397-403
ISSN: 1094-7159
Source: NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol.18, Iss.5, 2015-07, pp. : 397-403
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract